Calypso Biotech
Business Services · Switzerland · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Chemin Des Aulx 14, Plan-les-Ouates, Gen...Phone Number
+41 225523307Website
www.calypsobiotech.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Calypso Biotech
Calypso Biotech is an immunotherapy biotech company, spin-off from Merck Serono, that discovers and develops monoclonal antibodies for the treatment of immune pathologies with large, unmet medical needs. Calypso Biotech is headquartered in Amsterdam, the Netherlands, with offices and laboratories in Geneva, Switzerland, and is also a resident company of Johnson & Johnson Innovation -JLABS (JLABS @ BE) in Beerse, Belgium, a premier life science incubator program.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Calypso Biotech your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Click to see if Calypso Biotech had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Calypso Biotech has new funding data
Congratulate Masked Content for being promoted to Masked Content at Calypso Biotech
Calypso Biotech, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Calypso Biotech is spiking on competitors!
Earning: See what the market has to say on Calypso Biotech recently announced quarterly report
Check if Calypso Biotech has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Calypso Biotech launches new products
Recommended Actions
Find VP level buyers at Calypso Biotech
Find 3 more new buyers
Company Profile Activity
Activity Insights
Calypso Biotech is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Calypso Biotech is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Calypso Biotech.
Calypso Biotech financials insights
Gather financial insights about Calypso Biotech, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2019
Series A
$16.1M
Calypso Biotech Tech Stack
A closer look at the technologies used by Calypso Biotech
Calypso Biotech News & Media
Irish VC Fountain Healthcare participates in Calypso Biotech's $28m Series A - Silicon Republic
The Dutch start-up will use the funds from Fountain Healthcare and others to progress its research into novel autoimmune disease treatment.Calypso Biotech Announces First Patient With Celiac Disease Dosed in anti-Interleukin-15 (IL-15) Monoclonal Antibody CALY-002 Phase 1b Trial, and Extension of Series A to €28M
AMSTERDAM--(BUSINESS WIRE)--Calypso Biotech announces first patient with Celiac Disease dosed in Phase 1b Trial. Fountain Healthcare invests extending Series A to €28million.Calypso Biotech Announces First Patient With Celiac Disease Dosed in anti-Interleukin-15 ...
AMSTERDAM, September 09, 2021--Calypso Biotech announces first patient with Celiac Disease dosed in Phase 1b Trial. Fountain Healthcare invests extending Series A to €28million.Calypso Biotech Completes CALY-002 Clinical Batch Manufacturing
AGC Biologics, a global biopharmaceutical Contract Development Manufacturing Organization (CDMO), produces a GMP-grade clinical batch of CALY-002 for Calypso Biotech. The immunotherapy biotech company retained the services of AGC Biologics for the development of the manufacturing process and the production of its clinical supply.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Calypso Biotech
Sign Up For FreeTo access detailed company insights
Calypso Biotech is an immunotherapy biotech company, spin-off from Merck Serono, that discovers and develops monoclonal antibodies for the treatment of immune pathologies with large, unmet medical needs. Calypso Biotech is headquartered in Amsterdam, the Netherlands, with offices and laboratories in Geneva, Switzerland, and is also a resident compa... Read More
